VivoSeq
Other

Clinical Pharmacology

0

Pipeline Programs

3

Active Trials

11

Companies Involved

Clinical Pharmacology is an early-stage landscape with 0 programs across 11 companies. The most active players are Tanabe Pharma Corporation, Chiesi Farmaceutici S.p.A., Pfizer.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

28

clinical trials

Completed25 · 89%
Active, not recruiting2 · 7%
Recruiting1 · 4%

Trial Activity

28 trials

Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Completed··N/A·NCT00823407·12 enrolled
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)
Completed·Pfizer logoPfizer·Phase 1·NCT01026415·73 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)